Showing results (61-70 of 365) with videos related to

Sort By:
Pageof 37
Journal of Medical Genetics|October 10, 1997
Cost effectiveness of DNA diagnosis for four monogenic diseasesA A van der Riet, B A van Hout, F F Rutten
Mechanisms of Ageing and Development|August 24, 2010
Caloric restriction and aging but not overexpression of SOD1 affect hippocampal volumes in miceBart P F Rutten, Ivona Brasnjevic, Harry W M Steinbusch, et al.
The American Journal of Cardiology|March 20, 1990
Clinical benefits and cost-effectiveness of lowering serum cholesterol levels: the case of simvastatin and cholestyramine in The NetherlandsL L Martens, F F Rutten, D W Erkelens, et al.
Pharmacoeconomics|April 8, 1993
Effects of ACE inhibitors on heart failure in The Netherlands: a pharmacoeconomic modelB A van Hout, G Wielink, G J Bonsel, et al.
Mechanisms of Ageing and Development|March 29, 2003
The aging brain: less neurons could be betterBart P F Rutten, Hubert Korr, Harry W M Steinbusch, et al.
Current Alzheimer Research|January 26, 2012
The role of 5-hydroxymethylcytosine in aging and Alzheimer's disease: current status and prospects for future studiesDaniel L A van den Hove, Leonidas Chouliaras, Bart P F Rutten
The American Journal of Medicine|October 16, 1989
Cost effectiveness of cholesterol-lowering therapy in The Netherlands. Simvastatin versus cholestyramineL L Martens, F F Rutten, D W Erkelens, et al.
Journal of Health Economics|May 8, 1995
The friction cost method for measuring indirect costs of diseaseM A Koopmanschap, F F Rutten, B M van Ineveld, et al.
Pageof 37